152 related articles for article (PubMed ID: 37578974)
1. Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility.
Kumpula TA; Vorimo S; Mattila TT; O'Gorman L; Astuti G; Tervasmäki A; Koivuluoma S; Mattila TM; Grip M; Winqvist R; Kuismin O; Moilanen J; Hoischen A; Gilissen C; Mantere T; Pylkäs K
PLoS Genet; 2023 Aug; 19(8):e1010889. PubMed ID: 37578974
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
3. copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.
Kuusisto KM; Akinrinade O; Vihinen M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
PLoS One; 2013; 8(8):e71802. PubMed ID: 23967248
[TBL] [Abstract][Full Text] [Related]
4. Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Pelttari LM; Shimelis H; Toiminen H; Kvist A; Törngren T; Borg Å; Blomqvist C; Bützow R; Couch F; Aittomäki K; Nevanlinna H
Clin Genet; 2018 Mar; 93(3):595-602. PubMed ID: 28802053
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer.
Koivuluoma S; Tervasmäki A; Kauppila S; Winqvist R; Kumpula T; Kuismin O; Moilanen J; Pylkäs K
Eur J Cancer; 2021 Jan; 143():46-51. PubMed ID: 33279852
[TBL] [Abstract][Full Text] [Related]
6. Exome-wide analysis of copy number variation shows association of the human leukocyte antigen region with asthma in UK Biobank.
Fawcett KA; Demidov G; Shrine N; Paynton ML; Ossowski S; Sayers I; Wain LV; Hollox EJ
BMC Med Genomics; 2022 May; 15(1):119. PubMed ID: 35597955
[TBL] [Abstract][Full Text] [Related]
7. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
[TBL] [Abstract][Full Text] [Related]
8. Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network.
Pylkäs K; Vuorela M; Otsukka M; Kallioniemi A; Jukkola-Vuorinen A; Winqvist R
PLoS Genet; 2012; 8(6):e1002734. PubMed ID: 22737080
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
10. The Identification by Exome Sequencing of Candidate Genes in
BenAyed-Guerfali D; Kifagi C; BenKridis-Rejeb W; Ammous-Boukhris N; Ayedi W; Khanfir A; Daoud J; Mokdad-Gargouri R
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893033
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease.
Mortreux J; Bacquet J; Boyer A; Alazard E; Bellance R; Giguet-Valard AG; Cerino M; Krahn M; Audic F; Chabrol B; Laugel V; Desvignes JP; Béroud C; Nguyen K; Verschueren A; Lévy N; Attarian S; Delague V; Missirian C; Bonello-Palot N
J Hum Genet; 2020 Mar; 65(3):313-323. PubMed ID: 31852984
[TBL] [Abstract][Full Text] [Related]
12. Germline copy number variation analysis in Finnish families with hereditary prostate cancer.
Laitinen VH; Akinrinade O; Rantapero T; Tammela TL; Wahlfors T; Schleutker J
Prostate; 2016 Feb; 76(3):316-24. PubMed ID: 26552734
[TBL] [Abstract][Full Text] [Related]
13. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.
Bobyn A; Zarrei M; Zhu Y; Hoffman M; Brenner D; Resnick AC; Scherer SW; Gallo M
BMC Med Genet; 2020 May; 21(1):92. PubMed ID: 32375678
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R
Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962
[TBL] [Abstract][Full Text] [Related]
15. Germline copy number variations are associated with breast cancer risk and prognosis.
Kumaran M; Cass CE; Graham K; Mackey JR; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2017 Nov; 7(1):14621. PubMed ID: 29116104
[TBL] [Abstract][Full Text] [Related]
16. Rare copy number variation in cerebral palsy.
McMichael G; Girirajan S; Moreno-De-Luca A; Gecz J; Shard C; Nguyen LS; Nicholl J; Gibson C; Haan E; Eichler E; Martin CL; MacLennan A
Eur J Hum Genet; 2014 Jan; 22(1):40-5. PubMed ID: 23695280
[TBL] [Abstract][Full Text] [Related]
17. Copy Number Variation in
Wang Y; Li L; Yang Y; Feng J; Wang L; Zhang H
Genet Test Mol Biomarkers; 2020 Apr; 24(4):173-180. PubMed ID: 32208937
[No Abstract] [Full Text] [Related]
18. Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data.
Glessner JT; Bick AG; Ito K; Homsy J; Rodriguez-Murillo L; Fromer M; Mazaika E; Vardarajan B; Italia M; Leipzig J; DePalma SR; Golhar R; Sanders SJ; Yamrom B; Ronemus M; Iossifov I; Willsey AJ; State MW; Kaltman JR; White PS; Shen Y; Warburton D; Brueckner M; Seidman C; Goldmuntz E; Gelb BD; Lifton R; Seidman J; Hakonarson H; Chung WK
Circ Res; 2014 Oct; 115(10):884-896. PubMed ID: 25205790
[TBL] [Abstract][Full Text] [Related]
19. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
DeVries AA; Dennis J; Tyrer JP; Peng PC; Coetzee SG; Reyes AL; Plummer JT; Davis BD; Chen SS; Dezem FS; Aben KKH; Anton-Culver H; Antonenkova NN; Beckmann MW; Beeghly-Fadiel A; Berchuck A; Bogdanova NV; Bogdanova-Markov N; Brenton JD; Butzow R; Campbell I; Chang-Claude J; Chenevix-Trench G; Cook LS; DeFazio A; Doherty JA; Dörk T; Eccles DM; Eliassen AH; Fasching PA; Fortner RT; Giles GG; Goode EL; Goodman MT; Gronwald J; ; ; Håkansson N; Hildebrandt MAT; Huff C; Huntsman DG; Jensen A; Kar S; Karlan BY; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Le ND; Lubiński J; May T; Menon U; Milne RL; Modugno F; Monteiro AN; Moysich KB; Odunsi K; Olsson H; Pearce CL; Pejovic T; Ramus SJ; Riboli E; Riggan MJ; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Sieh W; Song H; Sutphen R; Terry KL; Thompson PJ; Titus L; Tworoger SS; Van Nieuwenhuysen E; Edwards DV; Webb PM; Wentzensen N; Whittemore AS; Wolk A; Wu AH; Ziogas A; Freedman ML; Lawrenson K; Pharoah PDP; Easton DF; Gayther SA; Jones MR
J Natl Cancer Inst; 2022 Nov; 114(11):1533-1544. PubMed ID: 36210504
[TBL] [Abstract][Full Text] [Related]
20. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
